Investors Overview

Webcast ImageWebcast
Q4 2014 Bacterin International Holdings Inc Earnings Conference Call (Replay)
03/18/15 at 10:00 a.m. ET
Q4 2014 Bacterin International Holdings Inc Earnings Conference Call
Wednesday, March 18, 2015 10:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Bacterin International Holdings Inc at ROTH Capital 27th Annual Conference (Replay)
03/11/15 at 12:30 p.m. PT
Bacterin International Holdings Inc at ROTH Capital 27th Annual Conference
Wednesday, March 11, 2015 12:30 p.m. PT  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Bacterin International Holdings Inc at Canaccord Genuity Musculoskeletal Conference (Replay)
03/24/15 at 2:00 p.m. PT
Bacterin International Holdings Inc at Canaccord Genuity Musculoskeletal Conference
Tuesday, March 24, 2015 2:00 p.m. PT  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile

Bacterin International Holdings, Inc., Belgrade, MT (NYSE: BONE), a developer of bioactive coatings for medical applications and revolutionary bone graft material, processes and markets innovative, biologic allografts for transplantation. The Company’s biologic scaffolds, OsteoSponge®, OsteoSponge® SC and OsteoWrap®, are made from demineralized bone that is malleable and flexible, which enables more efficient and precise handling. It also markets BacFast® and OsteoLock®, which are used in ...
More

Stock Quote
BONE (Common Stock)
ExchangeNYSE (US Dollar)
Price$4.26
Change (%) Stock is Up 0.12 (2.90%)
Volume4,483
Data as of 03/30/15 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Stock Chart
Stock chart for: 03NA000000BONE
Recent News
DateTitle 
03/17/15Bacterin Announces Fourth Quarter and Year-End 2014 Results
Fourth Quarter Highlights: Total revenue increased to $9.1 million from $8.3 million in Q4 2013, an increase of 10.0% over the prior year Gross profit increased to $5.8 million compared to $4.1 million in Q4 2013, an increase of 41.2% over the prior year Gross margins improved to 63.5%, an increase from 49.5% reported in the fourth quarter of 2013 Loss from operations before impairment decreased to $1.6 million from $2.8 million in the prior year BELGRADE, Mont., ... 
Printer Friendly Version
03/16/15Bacterin Announces Contract Extension With Novation
BELGRADE, Mont., March 16, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material, today announced that it has extended its contract with Novation for an additional year. The extension will allow Bacterin to continue to supply Novation members with OsteoSponge, OsteoSelect DBM Putty, and other proprietary Bacterin allografts. Novation develops and manages competitive contracts with more than 700 suppliers. As a biolo... 
Printer Friendly Version
03/11/15Bacterin to Present at the Canaccord Genuity Musculoskeletal Conference
BELGRADE, Mont., March 11, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone grafts, today announced that its CEO, Dan Goldberger, will present at the Canaccord Genuity Musculoskeletal Conference, to be held March 24, 2015 at the MGM Grand in Las Vegas, NV. Bacterin's presentation will take place Tuesday, March 24, 2015 at 2:00pm PT. Bacterin also will be in Las Vegas exhibiting the Company's biologic technologie... 
Printer Friendly Version
03/10/15Bacterin Announces Distribution Agreement With Spartan Medical for DOD and VA Medical Centers
BELGRADE, Mont., March 10, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material, today announced it has signed a national distribution agreement with Spartan Medical, Inc., a service-disabled, veteran-owned, small business focused on distribution to government medical facilities. Under the agreement, Spartan Medical will distribute Bacterin's proprietary product portfolio to the medical centers affiliated with the ... 
Printer Friendly Version
More

Upcoming Events
There are currently no events scheduled.
More

Receive E-mail Alerts
Sign up to receive e-mail alerts whenever Bacterin International Holdings Inc posts new information to the site. Just enter your e-mail address and click Submit.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.